Sukeshi Patel Arora, Lorena Fuentes, James Denno, Jennifer Moseley, Brittany M. Altermatt, Elizabeth Diaz, Joshua Ray Smith, Joel Michalek, Lei Zheng
读摘要原文 →
AACR 2026 年会
2026 年 4 月 17–22 日 · San Diego · 共 2429 条
tremelimumab
临床试验3 人 · 3 条 · 2 篇摘要
Alberto Giovanni Leone, Alessandra Raimondi, Paolo Manca, Sabina Murgioni, Giovanni G. Cardellino, Alessandro Bittoni, Antonia Strippoli, Maria Bencivenga, Federica Palermo, Floriana Nappo, Silvio K. Garattini, Thereasa Rich, Gaia Rebecchi, Roberta Fazio, Camilla Damonte, Margherita Ambrosini, Cecilia Villa, Greta Gronchi, Sara Lonardi, Filippo Pietrantonio
读摘要原文 →专家解读(YouTube)精选评分7171 肝癌关注月专家播客:EMERALD-3 三期数据与肝胆肿瘤治疗策略更新
VJOncology 发布肝癌关注月专题播客,多位专家解读晚期肝细胞癌与肝胆肿瘤治疗进展。Ghassan Abou-Alfa 介绍 EMERALD-3 三期试验。
推荐理由:播客给出 EMERALD-3 三期 STRIDE+TACE 对比 TACE 的 PFS 与 OS 数字,为评估免疫联合栓塞在中期 HCC 中的增益提供具体对照。
还没有互动
AACR 官方会议报道评分6060 Clinical Trials Plenary: New Results from Immunotherapy Regimen Trials
Final Clinical Trials Plenary, 'Advances in Immunotherapy', chaired by Ryan Sullivan (Massachusetts General Hospital). Alberto Giovanni Leone (Istituto Nazionale dei Tumori) presented phase II INFINITY data on tremelimumab plus durvalumab for organ preservation in MSI-high tumours.